Aelis Farma Logo

Aelis Farma

AELIS | PA

Overview

Corporate Details

ISIN(s):
FR0014007ZB4
LEI:
8945008D5R6WV7EXRN47
Country:
France
Address:
1 RUE LAFAURIE DE MONBADON, 33000 BORDEAUX
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Aelis Farma is a clinical-stage biopharmaceutical company specializing in the development of treatments for brain and central nervous system (CNS) disorders. The company is pioneering a new class of drugs known as Signaling Specific inhibitors of the CB1 receptor (CB1-SSi). This proprietary technology represents a unique mechanism of action designed to treat brain pathologies by selectively blocking the hyperactivity of the CB1 receptor without interfering with its normal physiological functions. This approach aims to provide safer and more effective therapies for conditions with high unmet medical needs. The company's lead drug candidates include AEF0117 for cannabis-related disorders and AEF0217 for cognitive deficits, including those associated with Down syndrome.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Aelis Farma. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-06-24 18:39
Share Issue/Capital Change
Acquisition ou cession des actions de l'émetteur / Modalités de mise à disposit…
French 274.1 KB
2025-06-24 18:39
Transaction in Own Shares
Acquisition or disposal of the issuer's own shares / Terms of availability of t…
English 269.1 KB
2025-05-27 18:00
Post-Annual General Meeting Information
Inside Information / Other news releases
English 246.2 KB
2025-05-27 18:00
Post-Annual General Meeting Information
Informations privilégiées / Autres communiqués
French 250.5 KB
2025-05-06 18:00
Pre-Annual General Meeting Information
Terms of availability of the preparatory documents for the GM
English 269.8 KB
2025-05-06 18:00
Pre-Annual General Meeting Information
Modalités de mise à disposition des documents préparatoires à l'AG
French 255.0 KB
2025-04-29 18:00
Report Publication Announcement
Rapports financiers et d'audit annuels / Modalités de mise à disposition du rap…
French 243.9 KB
2025-04-29 18:00
Registration Form
Annual financial and audit reports / Terms of availability of the annual financ…
English 260.7 KB
2025-04-28 15:28
Annual Report (ESEF)
DEU 2024
French 22.6 MB
2025-04-01 18:26
Earnings Release
Inside Information / News release on accounts, results
English 375.3 KB
2025-04-01 18:26
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
French 463.0 KB
2025-03-26 18:00
Earnings Release
Inside Information / Other news releases
English 339.9 KB
2025-03-26 18:00
Regulatory News Service
Informations privilégiées / Autres communiqués
French 432.0 KB
2025-03-24 10:31
Major Shareholding Notification
Franchissement de seuils
French 205.4 KB
2025-01-08 18:00
Regulatory News Service
Acquisition ou cession des actions de l'émetteur / Information relative au cont…
French 373.0 KB

Automate Your Workflow. Get a real-time feed of all Aelis Farma filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Aelis Farma via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Makes saliva-based diagnostics accessible for at-home & pro health & drug monitoring.
Sweden AEGIR
AGRONOMICS LIMITED Logo Isle of Man ANIC
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK
Alkaloid AD Logo
Manufacturing pharmaceuticals, cosmetics, and botanicals for consumer and healthcare markets.
North Macedonia ALK